Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
NMTC NEUROONE MEDICAL TECHNOLOGIES Corp
- Stocks
- Healthcare
- NASDAQ: NMTC
Price (delayed)
$0.6021
Market cap
$30M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.22
Enterprise value
$28.88M
Highlights
The gross margin has soared by 138% YoY and by 7% QoQ
NMTC's revenue has surged by 135% year-on-year
NEUROONE MEDICAL TECHNOLOGIES's equity has plunged by 71% YoY and by 62% from the previous quarter
The quick ratio has shrunk by 58% QoQ and by 52% YoY
Key stats
What are the main financial stats of NMTC
Market
Valuations
Earnings
Shares outstanding
49.82M
Market cap
$30M
Enterprise value
$28.88M
Price to earnings (P/E)
N/A
Price to book (P/B)
16.51
Price to sales (P/S)
2.14
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.3
Revenue
$8.76M
Gross profit
$6.12M
Operating income
-$6.58M
Net income
-$6.6M
EBIT
-$6.6M
EBITDA
-$6.24M
Free cash flow
-$4.95M
Per share
Balance sheet
Liquidity
EPS
-$0.22
EPS diluted
-$0.22
Free cash flow per share
-$0.16
Book value per share
$0.04
Revenue per share
$0.28
TBVPS
$0.14
Total assets
$4.46M
Total liabilities
$3.33M
Debt
$206,973
Equity
$1.13M
Working capital
$1.99M
Debt to equity
0.18
Current ratio
2.13
Quick ratio
0.93
Net debt/EBITDA
0.18
Margins
Efficiency
Dividend
EBITDA margin
-71.2%
Gross margin
69.9%
Net margin
-75.4%
Operating margin
-75.1%
Return on assets
-124.4%
Return on equity
-334.6%
Return on invested capital
-291.8%
Return on capital employed
-245.2%
Return on sales
-75.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NMTC stock price
How has the NEUROONE MEDICAL TECHNOLOGIES stock price performed over time
Intraday
8.02%
1 week
-5.14%
1 month
-3.74%
1 year
-34.55%
YTD
-27.1%
QTD
-29.18%
Financial performance
How have NEUROONE MEDICAL TECHNOLOGIES's revenue and profit performed over time
Revenue
$8.76M
Gross profit
$6.12M
Operating income
-$6.58M
Net income
-$6.6M
Gross margin
69.9%
Net margin
-75.4%
The gross margin has soared by 138% YoY and by 7% QoQ
NMTC's revenue has surged by 135% year-on-year
The company's net margin has surged by 78% YoY and by 8% QoQ
NMTC's operating margin has soared by 78% YoY and by 3.2% from the previous quarter
Price vs fundamentals
How does NMTC's price correlate with its fundamentals
Growth
What is NEUROONE MEDICAL TECHNOLOGIES's growth rate over time
Valuation
What is NEUROONE MEDICAL TECHNOLOGIES stock price valuation
P/E
N/A
P/B
16.51
P/S
2.14
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.3
The EPS has soared by 62% year-on-year and by 15% since the previous quarter
The P/B is 74% above the 5-year quarterly average of 9.5 but 14% below the last 4 quarters average of 19.1
NEUROONE MEDICAL TECHNOLOGIES's equity has plunged by 71% YoY and by 62% from the previous quarter
NMTC's revenue has surged by 135% year-on-year
The price to sales (P/S) is 94% lower than the 5-year quarterly average of 36.3 and 55% lower than the last 4 quarters average of 4.8
Efficiency
How efficient is NEUROONE MEDICAL TECHNOLOGIES business performance
The ROS has soared by 78% year-on-year and by 8% since the previous quarter
The company's return on invested capital has surged by 72% YoY and by 10% QoQ
NMTC's ROA is up by 39% YoY and by 4.1% from the previous quarter
The return on equity has declined by 24% since the previous quarter and by 20% year-on-year
Dividends
What is NMTC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NMTC.
Financial health
How did NEUROONE MEDICAL TECHNOLOGIES financials performed over time
The total assets is 34% greater than the total liabilities
NMTC's total liabilities has soared by 116% YoY but it is down by 6% from the previous quarter
The quick ratio has shrunk by 58% QoQ and by 52% YoY
The company's debt is 82% lower than its equity
NMTC's debt to equity has soared by 125% QoQ
NEUROONE MEDICAL TECHNOLOGIES's equity has plunged by 71% YoY and by 62% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.